As expected, diseases with regionally specific and pronounced atrophy patterns such as svPPA, AD, and PSP were generally better classified than diseases with widespread and rather weak atrophy such as CBS (see Fig. 4). This evidence concerns the gene CBS and Alzheimer disease.